| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
DEERFIELD, Ill.—Advanced Clinical, a clinical development organization providing contract research, functional service provider, strategic resourcing and quality and validation services, announced in late June that it has joined Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and contract research organizations to work together during clinical trials.
 
“Align Clinical CRO’s mission is directly in line with our goal of delivering a better clinical experience to sponsors. As a member of this powerful industry collaboration, we will help develop and drive new technology standards that will improve operational delivery of clinical trials,” said Julie Ross, president of Advanced Clinical.
 
Align Clinical CRO aims to develop and support the adoption of open technology standards that make it easier for industry sponsors and CROs to collaborate and execute clinical trials. Founded by Veeva Systems and leading CROs, the group’s first standard for operational data exchange will define the data and structure that technology companies can implement in order to consistently and easily exchange clinical trial data between CROs and sponsors. With more efficient CRO-sponsor data exchange, these standards will reduce clinical trial start up time and operational costs while improving data integrity and service delivery.
 
The Operational Data Exchange Standard is expected to be published for public review and input later this year.

Related Topics

Published In

Volume 14 - Issue 7 | July 2018

July 2018

July 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue